HPLC versus LC-MS: what each analytical method does — and does not — tell you

Most research-compound Certificates of Analysis cite two techniques: high-performance liquid chromatography (HPLC) and liquid chromatography–mass spectrometry (LC-MS). They are frequently treated as interchangeable. They are not.

HPLC: separating and quantifying

HPLC separates the components of a sample as they pass through a column under pressure. For peptides, reverse-phase HPLC is standard: a non-polar stationary phase (commonly C18) and a gradient of increasing organic solvent elute components roughly in order of hydrophobicity. A UV detector — usually at 210–220 nm, where the peptide bond absorbs — records a chromatogram.

Purity by HPLC is the area of the main peak divided by the total area of all peaks, expressed as a percentage. It is a relative measure with important caveats:

• Only components that absorb at the detection wavelength are counted. Salts, water and many solvents are invisible.
• Co-eluting impurities (for example a deletion sequence with similar hydrophobicity) can hide under the main peak.
• Integration parameters — where the baseline is drawn, which small peaks are included — affect the figure.

HPLC alone does not confirm what the main peak is. A sample of the wrong peptide can be 99% "pure".

LC-MS: confirming what the peak is

LC-MS couples the same chromatographic separation to a mass spectrometer. As each component elutes, its mass-to-charge ratio is measured. For a peptide, the result is compared with the mass calculated from the intended sequence.

Identity by LC-MS means the observed mass matches the expected mass within the instrument's accuracy. Peptides typically appear as multiply charged ions, which software deconvolutes to a neutral mass. Modifications — acetylation, amidation, fatty-acid side chains, disulfide bridges — all shift the mass predictably, so a correct match is good evidence that the intended molecule is present.

Limitations:

• Isomers (for example D- versus L-amino acids, or a scrambled sequence of the same residues) have identical masses. LC-MS cannot distinguish them; retention time and other methods are needed.
• A matching mass confirms presence, not proportion. Semi-quantitative statements from MS should be treated cautiously unless a validated method is stated.

Reading the two together

A well-documented batch shows both: an HPLC purity with its method, and an LC-MS identity with observed and expected masses. Together they say "the main component is the intended molecule, and it makes up X% of the UV-absorbing material".

Even then, remember that neither method measures net peptide content (the fraction of the powder that is peptide rather than water and counter-ion). That requires amino acid analysis, nitrogen determination or a validated quantitative assay.

Other methods you may see

• MALDI-TOF MS: an alternative identity method, common for larger peptides.
• Amino acid analysis (AAA): hydrolyses the peptide and quantifies amino acids; supports both identity (composition) and net content.
• Karl Fischer titration: water content.
• Ion chromatography: counter-ion content (acetate, TFA).
• Endotoxin (LAL) and bioburden: relevant for cell-culture and in-vivo work; absence of these tests means nothing has been established about them.

A worked example of what to ask

Suppose a COA reports "Purity 98.6% (HPLC)" and "Identity: conforms (LC-MS)".

Useful follow-up questions: What column and wavelength? What were the observed and expected masses? Was net peptide content measured? What is the counter-ion? When was the sample tested, and how has it been stored since?

When Positive Peptides states a result, the method behind it is stated with it, so these questions can be answered rather than assumed.

This article is for scientific information only.